ATHA

Athira Pharma is a biotechnology company that researches and develops potential treatments for neurodegenerative diseases, primarily focusing on Alzheimer's disease. The company creates experimental drugs that target specific biological pathways in the brain, which it tests through clinical trials with patients. Athira makes money through research funding, partnerships with larger pharmaceutical companies, and would generate revenue from drug sales if any of its treatments receive regulatory approval and reach the market.